TherapeuticsMD, Inc.
(NASDAQ GS: TXMD)
Rigrodsky Law, P.A. is investigating TherapeuticsMD, Inc. (“TXMD”) regarding possible breaches of fiduciary duties and other violations of law related to TXMD’s agreement to be acquired by an affiliate of EW Healthcare Partners. Under the terms of the agreement TXMD’s shareholders will receive $10.00 in cash for each share of TXMD common stock they own.